LUCY NUSRALA: Open Payments
NPI 1821087891 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,394 in 155 payments from 17 companies in 2025. Trend: 2023 $1,803 · 2024 $3,294 · 2025 $3,394
Food & beverage: $3,292Education: $102
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 48 | $905 |
| UCB, Inc. | 20 | $610 |
| ABBVIE INC. | 15 | $298 |
| Lilly USA, LLC | 10 | $274 |
| Novartis Pharmaceuticals Corporation | 15 | $244 |
| Galderma Laboratories, L.P. | 5 | $226 |
| Incyte Corporation | 11 | $158 |
| Regeneron Healthcare Solutions, Inc. | 7 | $154 |
| PFIZER INC. | 9 | $143 |
| Organon LLC | 4 | $139 |
Products named: TREMFYA, Bimzelx, COSENTYX, NEMLUVIO, DUPIXENT, SKYRIZI, OPZELURA, TALTZ.
Industry payments across OR — which companies pay providers there.
